Uncategorized

TTBD brown bag: Evaluating a licensing opportunity, June 12

When a company looks at bringing in a new technology to commercialize, they perform due diligence on a wide array of different topics to allay the potential risks. What are these risks and what kind of questions do they ask? What kind of information can we provide to maximize interest and licensing revenue? In this presentation, TTBD Technology Development Managers, Rob Copenhaver and Trina Voss, will discuss the questions companies ask when evaluating a licensing … Read More

Seminar: Modeling change in the presence of measurement error, May 30

Please join us for a special biostatistics presentation, featuring David Yanez, Ph.D., an associate professor in the Department of Biostatistics at University of Washington. Dr. Yanez has been involved in a wide variety of collaborative clinical and translational research. His statistical methodology interests include analysis of overdispersed data, joint modeling of mean and dispersion parameters and quasi-likelihood models, as well as his current interest in models for measurement error. He will present recent work in this latter … Read More

New Clinical & Translational Research Center and Epilepsy Monitoring Unit open house, April 29

OCTRI’s Clinical and Translational Research Center and Epilepsy Monitoring Unit has recently undergone construction to provide first class care and research capabilities. Supported by heightened staffing, space and state-of-the-art equipment, this new unit will strengthen and elevate the care of patients with neurologic diseases and support clinical research across a broad spectrum. Please join us for an open house to learn more about the facility, tour and enjoy refreshments. Clinical and Translational Research Center and … Read More

Major changes to NIH and AHRQ grant resubmission policy that will make your life easier and better

Few things are as frustrating as writing a great grant that is not funded because the funding percentile is so low–and then having to figure out how to drastically revise it to meet the requirement of writing a “new” application. Effective now, that pain point is going away: As of April 17, 2014, the NIH and AHRQ no longer require new (A0) grant applications to demonstrate significant changes in scientific direction, even if the project was … Read More

Heart Research Center becomes the Center for Developmental Health

The $125 million gift from Nike co-founder and Chairman Phil Knight and his wife Penny that formed the OHSU Knight Cardiovascular Institute has rallied researchers around the developmental origins of cardiovascular disease. This gift has already inspired many changes as the institute works to become a leader in translational cardiovascular research. One major change is the transition of the Heart Research Center into the newly formed Center for Developmental Health to reflect a focus on … Read More

OHSU Technology Transfer and Business Development newsletter

Check out the Technology Transfer & Business Development 2014 first quarter Newsletter. In this issue, we discuss:  Business Development Updates – Hear about the Business Development Research Consortia and how our second annual Startup Symposium was a great success United States Legislation Update – Keep up-to-date on “the Innovation Act” and “the Transfer Act of 2013” and how it might affect you TTBD Patent Evaluation Process – Learn more about our patent evaluation process along with the requirements to … Read More

Winter weather impacts on shipping

As of 12 p.m. on Friday, Dec. 5, FedEx has informed OHSU that they will be picking up early today due to the weather. This will cause the shipping department to discontinue services at 2 p.m. this afternoon. If you have an urgent package that needs to be shipped today, check with the shipping office at ext. 4-7380. Please visit the Staff News blog for continued winter weather updates.

OHSU & Shriners Faculty Member Lynn Sakai noted in the New York Times

The New York Times December 2 “Science” section featured the work of Lynn Sakai, Ph.D., Senior Investigator at the Portland Shriners Research Center and Professor of Biochemistry & Molecular Biology, OHSU. Dr. Sakai and her colleagues have been studying the use of fibrillin-1 levels–the protein associated with Marfan syndrome–as a blood test for aortic ruptures. Read the Times feature here.

Register for Gene Therapy at OHSU symposium by Nov. 6

The OHSU Gene Therapy Working Group and the Rare Disorders Research Consortium invite you to attend the 2nd Annual Gene Therapy Symposium, an afternoon event to showcase OHSU’s Gene Therapy research excellence. “Gene Therapy at OHSU” Thursday, November 21, 2013 2 to 6:30 p.m. The Joseph Vey Conference Center Featuring “Genes and Non Coding RNAs as Therapeutics” by keynote speaker Mark A. Kay, M.D., Ph.D., Dennis Farrey Family Professor, Departments of Pediatrics and Medical Genetics, Stanford … Read More

OHSU Tech Transfer & Business Development fourth quarter newsletter

Find out about all of the latest happenings in Technology Transfer and Business Development (TTBD) at OHSU in the quarterly newsletter. Highlights include: The Guide to Technology Transfer and Business Development – A handy online document outlining how our office can assist you. Important patent law changes – What is happening with the Association for Molecular Pathology v. Myriad Genetics case and how does that relate to patents at OHSU? How to fast track your … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives